Sligo University Hospital is an acute general hospital in Sligo, Ireland. It is managed by Saolta University Health Care Group.

There are 359 beds in Sligo General Hospital.

During the past decade, Sligo General Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sligo General Hospital" #1 sponsor was "Cancer Trials Ireland" with 10 trials, followed by "NSABP Foundation Inc" with 3 trials sponsored, "National Cancer Institute (NCI)" with 3 trials sponsored, "Queen Mary University of London" with 2 trials sponsored and "Alliance Foundation Trials, LLC." with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sligo General Hospital" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "NSABP Foundation Inc" with 2 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator, "Austrian Breast & Colorectal Cancer Study Group" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Sligo General Hospital" are "Breast Cancer" (13 trials), "Cancer" (2 trials), "Colorectal Cancer" (2 trials), "Metastatic Breast Cancer" (2 trials) and "Prostate Cancer" (2 trials). Many other conditions were trialed in "Sligo General Hospital" in a lesser frequency.

Most popular intervention types in "Sligo General Hospital" are "Drug" (16 trials), "Other" (8 trials), "Biological" (2 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Anastrozole" (4 trials), "Letrozole" (4 trials), "Exemestane" (3 trials), "Laboratory Biomarker Analysis" (3 trials) and "Quality-of-Life Assessment" (3 trials). Other intervention names were less common.

The vast majority of trials in "Sligo General Hospital" are 15 trials for "Female" genders, 10 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Sligo General Hospital". undefined are not yet recruiting, 3 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Sligo General Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Sligo General Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Sligo General Hospital has several departments that took part in Clinical trials: "Galway Uni Hospital; Oncology Dept" - 7 trials